IART Key Statistics, Chart & Performance
The current stock price of IART is 13.12 USD. In the past month the price increased by 11.09%. In the past year, price decreased by -46.62%.
IART Latest News, Press Relases and Analysis
IART Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.83 | 224.14B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.61 | 203.30B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.43 | 150.59B | ||
| SYK | STRYKER CORP | 28.18 | 141.95B | ||
| IDXX | IDEXX LABORATORIES INC | 59.7 | 60.12B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.61B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.72 | 50.29B | ||
| RMD | RESMED INC | 25.84 | 37.34B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.43 | 36.44B | ||
| DXCM | DEXCOM INC | 34.12 | 24.75B | ||
| PODD | INSULET CORP | 71.6 | 23.02B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12.05 | 19.33B |
Related stock screener links
About IART
Company Profile
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,396 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Company Info
INTEGRA LIFESCIENCES HOLDING
1100 Campus Road
Princeton NEW JERSEY 08540 US
CEO: Peter J. Arduini
Employees: 4396
Phone: 16092750500
INTEGRA LIFESCIENCES HOLDING / IART FAQ
Can you describe the business of INTEGRA LIFESCIENCES HOLDING?
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. The company is headquartered in Princeton, New Jersey and currently employs 4,396 full-time employees. The firm manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.
Can you provide the latest stock price for INTEGRA LIFESCIENCES HOLDING?
The current stock price of IART is 13.12 USD.
Does INTEGRA LIFESCIENCES HOLDING pay dividends?
IART does not pay a dividend.
What is the ChartMill technical and fundamental rating of IART stock?
IART has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How many employees does INTEGRA LIFESCIENCES HOLDING have?
INTEGRA LIFESCIENCES HOLDING (IART) currently has 4396 employees.
What is the market capitalization of IART stock?
INTEGRA LIFESCIENCES HOLDING (IART) has a market capitalization of 1.02B USD. This makes IART a Small Cap stock.
What is the next earnings date for IART stock?
INTEGRA LIFESCIENCES HOLDING (IART) will report earnings on 2026-02-23, after the market close.
IART Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to IART. When comparing the yearly performance of all stocks, IART is a bad performer in the overall market: 89.48% of all stocks are doing better.
IART Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IART. There are concerns on the financial health of IART while its profitability can be described as average.
IART Financial Highlights
Over the last trailing twelve months IART reported a non-GAAP Earnings per Share(EPS) of 2.37. The EPS decreased by -4.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.58% | ||
| ROE | -47.74% | ||
| Debt/Equity | 1.73 |
IART Forecast & Estimates
17 analysts have analysed IART and the average price target is 15.81 USD. This implies a price increase of 20.5% is expected in the next year compared to the current price of 13.12.
For the next year, analysts expect an EPS growth of -12.37% and a revenue growth 1.34% for IART